• Journal of Genetic Medicine
• /
• 제15권2호
• /
• pp.107-109
• /
• 2018

X-linked Charcot-Marie-Tooth disease type 1 (CMTX1) is caused by the mutation in GJB1 gene, characterized by the transient central nervous system involvement and long standing peripheral polyneuropathy which does not fulfill the criteria of demyelination or axonopathy. We describe a 37-year-old man with progressive bilateral leg weakness since his early teen. He suffered transient right hemiparesis, followed by quadriparesis at 14 years of age. When we examined him at 37 years of age, he presented a distal muscle weakness on lower extremities with a sensory symptom. The nerve conduction study demonstrated a motor conduction velocity between 26 and 49 m/s. The whole exome sequencing revealed a novel variant c.136 G>A in GJB1. This report will raise awareness in this rare disease, which is frequently misdiagnosed early in its course.

• Annals of Clinical Neurophysiology
• /
• 제23권2호
• /
• pp.130-133
• /
• 2021

X-linked Charcot Marie Tooth disease type 1 (CMTX1) is a clinically heterogenous X-linked hereditary neuropathy caused by mutation of the gene encoding gap junction beta 1 protein (GJB1). Typical clinical manifestations of CMTX1 are progressive weakness or sensory disturbance due to peripheral neuropathy. However, there have been some CMTX1 cases with accompanying central nervous system (CNS) manifestations. We report the case of a genetically confirmed CMTX1 patient who presented recurrent transient CNS symptoms without any symptom or sign of peripheral nervous system involvement.

• Annals of Clinical Neurophysiology
• /
• 제7권2호
• /
• pp.65-74
• /
• 2005

Charcot-Marie-Tooth (CMT) disease was described by Charcot and Marie in France and, independently, by Tooth in England in 1886. CMT is the most common form of inherited motor and sensory neuropathy, and is a genetically heterogeneous disorder of the peripheral nervous system. Therefore, many genes have been identified as CMT-causative genes. Traditionally, subclassification of CMT have been divided into autosomal dominant inherited demyelinating (CMT1) and axonal (CMT2) neuropathies, X-linked neuropathy (CMTX), and autosomal recessive inherited neuropathy (CMT4). Recently, intermediate type (CMT-Int) with NCVs between CMT1 and CMT2 is considered as a CMT type. There are several related peripheral neuropathies, such as $D{\acute{e}}j{\acute{e}}rine$-Sottas neuropathy (DSN), congenital hypomyelination (CH), hereditary neuropathy with liability to pressure palsies (HNPP) and giant axonal neuropathy (GAN). Great advances have been made in understanding the molecular basis of CMT, and 17 distinct genetic causes of CMT have been identified. The number of newly discovered mutations and identified genetic loci is rapidly increasing, and this expanding list has proved challenging for physicians trying to keep up with the field. Identifying the genetic cause of inherited neuropathies is often important to determine at risk family members as well as diagnose the patient. In addition, the encouraging studies have been published on rational potential therapies for the CMT1A. Now, we develop a model of how the various genes may interact in the pathogenesis of CMT disorder.

• 생명과학회지
• /
• 제18권6호
• /
• pp.764-769
• /
• 2008

커넥신(connexin) 32 유전자의 돌연변이가 씨엠티엑스(CMTX, X-linked Charcot-Marie-Tooth) 질환과 관련이 있다. 현재까지 300여개 이상의 돌연변이가 보고가 되었으나 이 질환에 대한 상세한 분자병리학적 원인을 거의 알려져 있지 않고 있다. 여러 연구를 통해서 커넥신 세포막채널이 간극결합채널이 갖고 있는 대부분의 생물리학적 특성을 갖고 있는 것으로 판명되었다. 이번 연구에서는 씨엠티엑스 질환과 관련된 두 개의 돌연변이체를 선정하여 간극결합채녈 대신 돌연변이체로 구성된 커넥신 세포막채널을 이용하여 단일채널수준에서 이들 돌연변이체의 특성을 조사하였다. M34T 돌연변이 세포막채널의 생물리학적 특성은 이들로 구성된 돌연변이 간극결합채널의 특성과 거의 유사하였다. 더욱이, 돌연변이 세포막채널을 이용한 연구를 통해서 간극결합채널을 이용한 연구에서는 밝혀지지 않았던 개폐극성의 역전, 빠른 개폐의 소실과 느린 개폐의 생성과 같은 새로운 사실을 알게 되었다. T86C 돌연변이 세포막채널 또한 이의 모체가 되는 커넥신 32 세포막채널과 유사한 특성을 갖고 있음을 알게 되었다. 이상의 결과를 통해서 커넥신 세포막을 이용한 연구가 씨엠티엑스 질환의 돌연변이체를 연구하는데 매우 유용할 것으로 생각된다.